One Adult's Rare Deep Brain Tumor and Its Gene Changes
Original title: Adult Thalamic Diffuse Midline Glioma, H3 K27-Altered, With KRAS Comutation and Potential Early Subependymal Dissemination.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is one patient's story plus a look at where the science is heading.
The short version
Doctors share the story of one adult with a rare tumor deep inside the brain.
What was studied. Doctors report on one patient, a 54-year-old adult, with a rare tumor deep in the left side of the brain. They tested the tumor's genes and treated it with radiation, without the drug temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary.
What they found. The tumor was a diffuse midline glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary, grade 4, with gene changes called H3F3A H3 K27-altered: A change in a histone. A histone is a protein DNA wraps around. A diffuse glioma can have it. If it also sits in the middle of the brain or spine, it is called a diffuse midline glioma. See the glossary, KRAS G12V, and PHF6. Surgery was not safe because of where the tumor sat, so the patient had radiation alone. Later scans showed the tumor had gotten smaller, but a new small lump appeared near a fluid space in the brain, which raised worry about early spread.
What this means, and what it doesn't
What it could mean: Gene testing can help doctors understand this rare tumor when it shows up in adults. For this one person, radiation alone did shrink the tumor. The report also points to a drug called dordaviprone (ONC201) that doctors are studying for these tumors.
What it doesn't mean: This is one person's story, not a trial or a study of many people. It does not show that this plan will work for anyone else. It is not a cure, and it does not change the care your own team can offer you today. The gene changes found here are not proof that a new treatment works.
Source: PubMed, October 2, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.